Why this Peninsula company needs a cash fix 2 years after opioid addiction treatment approved

The drug-device is implanted in the arms of a limited scope of opioid abusers — and that's just one of Titan Pharmaceuticals' issues as it looks to be relaunch Probuphine in the United States on its own.